Individualized Ofatumumab versus Fixed Low‐Dose Rituximab in MuSK‐Antibody‐Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study

Clinical Neurology and Neurosurgery · Elsevier

Аннотация

Publication date: January 2027 Source: Clinical Neurology and Neurosurgery, Volume 272 Author(s): Qian Zhou, Yi Zhong, Weifan Yin, Fei Jiang, Qiuming Zeng, Guanzhong Shi, Yuzhen Ouyang, Ting He, Xiaohua Dong, Zeyi Wen, Haobing Cai, Wei Xiang, Liu Wang, Kailin Li, Huan Yang

Читать у издателя →

Похожие статьи